BRAF and neoplasm: Although they did not delineate the dose–response relationship of BRAF V600E mutation abundance, they proposed that BRAF mutation abundance could serve as an indicator for preoperative assessment of tumor aggressiveness and determination of surgical extent, which is consistent with our findings.